rfk and glp 1 Jr. Walks a Tightrope on Trump Deal for Obesity Drugs RFK Jr. on coverage for

That's not unusual for a newly launched brand

Zoicas F, Droste M, Mayr B, Buchfelder M, Schofl C

Great work, David, this is exactly the kind of awareness and practical frameworks we need around GLP-1 use

The good news is that muscle loss during weight loss is not inevitable if the right measures are in place

Microdosing, which involves starting with significantly lower doses (0.1mg to 0.25mg), aims to mitigate these adverse effects, making the therapy more tolerable for a broader range of patients

Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review